What does it mean when Melanoma spreads to the brain

MelanomaMay 18, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Brain Metastases in Melanoma

When melanoma spreads to the brain, it means cancer cells from the original skin melanoma have traveled through the bloodstream or lymphatic system and formed new tumors in the brain. These are called brain metastases or distant metastases — the medical term for cancer that has spread far from where it started.

How This Happens

According to the NCCN Guidelines for Patients: Melanoma, melanoma is "one of the most serious types of skin cancer because it spreads beyond the skin more often than many other skin cancers." When melanoma cells break away from the primary tumor, they can travel to distant organs, including the brain. This typically means the melanoma has progressed to stage 4 (metastatic disease) — the most advanced stage.

What This Means for Your Situation

Brain metastases represent a significant change in your cancer status because:

  • The cancer has spread systemically — meaning it's now in multiple parts of your body, not just localized to one area
  • Treatment becomes more complex — doctors must address both the brain tumors and any other metastatic disease
  • Your care team will need to reassess your overall treatment strategy and prognosis

Treatment Approaches for Brain Metastases

According to NCCN Guidelines, when melanoma spreads to the brain, treatment options typically include:

Radiation Therapy Options:

  • Stereotactic radiosurgery (SRS) — a highly precise, high-dose radiation treatment delivered in a single session, which is the preferred approach for brain metastases
  • Stereotactic radiotherapy (SRT) — similar to SRS but delivered over 1-5 sessions for larger or multiple tumors

Systemic Therapy:

  • Immunotherapy drugs (checkpoint inhibitors like nivolumab or pembrolizumab)
  • Targeted therapy (if you have a BRAF V600 mutation)
  • These systemic treatments can work throughout the body, including the brain

Combination Approaches: Your oncologist may recommend combining radiation with systemic therapy to address both the brain tumors and any other metastatic disease.

Important Questions to Ask Your Care Team

Since brain metastases require specialized treatment planning, consider asking your oncologist:

  1. How many brain tumors do I have, and how large are they? (This affects which treatment is best)
  2. Do I have a BRAF mutation or other biomarkers that would make me eligible for targeted therapy? (This could influence treatment selection)
  3. Will I receive radiation, systemic therapy, or a combination of both? (Understanding your specific plan is crucial)
  4. What are the potential side effects of brain radiation, and how will they be managed? (Brain radiation can affect cognition and other functions)
  5. Are there clinical trials available for melanoma with brain metastases? (New treatments are being studied)
  6. How will my treatment be coordinated between my oncologist and a neuro-oncologist? (Brain cancers often require specialized expertise)

The Bigger Picture

While brain metastases indicate advanced disease, it's important to know that more effective treatments have become available in the past decade for melanoma that has spread, according to NCCN Guidelines. Immunotherapy and targeted therapy have significantly improved outcomes for patients with metastatic melanoma, including those with brain involvement.

Your care team will develop a comprehensive treatment plan based on:

  • The number and size of brain tumors
  • Your genetic biomarkers (BRAF status, etc.)
  • Your overall health and performance status
  • Previous treatments you've received
  • Your personal preferences and goals

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Patients: Melanoma, 2025; American Cancer Society recommendations for metastatic melanoma

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: